Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

HSK 1 – For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languagesfree forever.

Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Ischemic Heart Disease

  Free Subscription


20.04.2026

2 Am Heart J
3 Am J Cardiol
2 Am J Med
3 Angiology
1 Ann Thorac Surg
1 Arterioscler Thromb Vasc Biol
1 Can J Cardiol
1 Catheter Cardiovasc Interv
1 Circ J
3 Circulation
2 Clin Cardiol
4 Eur Heart J
4 Int J Cardiol
3 J Am Coll Cardiol
3 Lancet
1 Mol Cell Biochem
9 N Engl J Med
1 PLoS Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. ZHAO J, Hong H, Fanaroff A, Zhong S, et al
    Advancing In-Hospital Mortality Prediction for Acute Myocardial Infarction: an analysis from the American Heart Association Get-With-the-Guidelines Coronary Artery Disease Registry.
    Am Heart J. 2026 Apr 14:107445. doi: 10.1016/j.ahj.2026.107445.
    PubMed         Abstract available

  2. LAVI S, Shadpour S, Allen E, Ogunsakin RE, et al
    Design and rational of the The PRACTICAL-HERO trial: a randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiography.
    Am Heart J. 2026 Apr 13:107441. doi: 10.1016/j.ahj.2026.107441.
    PubMed         Abstract available


    Am J Cardiol

  3. GNANARAJ JP, Saaminathan K, Steaphen AP, Sethupathy S, et al
    Extended Pharmacoinvasive PCI Compared to Primary PCI: Insights from Madras Medical College STEMI Registry.
    Am J Cardiol. 2026 Mar 2:S0002-9149(26)00116.
    PubMed         Abstract available

  4. SAMUELS A, Zolotarova T, Eisenberg MJ
    Cardiogenic Shock: A State-of-the-Art Review.
    Am J Cardiol. 2026;266:42-51.
    PubMed         Abstract available

  5. AGRAWAL A, Safdar A, Bhagat U, Rosenzveig A, et al
    Cardiovascular Complications During Delivery Hospitalizations in Patients with Infective Endocarditis.
    Am J Cardiol. 2026 Apr 15:S0002-9149(26)00225.
    PubMed         Abstract available


    Am J Med

  6. LAI JSY, Yeong N, Tan XY, Chen M, et al
    When troponin results lie: A narrative review and practical approach to spurious hypertroponinemia.
    Am J Med. 2026;139:626-633.
    PubMed         Abstract available

  7. KU L, Qiu R, Ma X
    Pheochromocytoma-Induced Angina Pectoris Mimicking Acute Coronary Syndrome.
    Am J Med. 2026 Apr 11:S0002-9343(26)00269-X. doi: 10.1016/j.amjmed.2026.
    PubMed        


    Angiology

  8. MUZUROVIC E, Zecevic K, Mantzoros CS
    Letter: Integrating Noninvasive Liver Indices into Risk Stratification of Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Angiology. 2026 Apr 10:33197261441899. doi: 10.1177/00033197261441899.
    PubMed        

  9. YE D, Xu J
    A Comparison of Carotid Ultrasound and Coronary Optical Coherence Tomography in Assessing Plaque Morphology in Patients With Chronic Coronary Syndrome.
    Angiology. 2026 Apr 15:33197261441995. doi: 10.1177/00033197261441995.
    PubMed        

  10. BAYICI BB, Kizilyel F
    Letter: Association Between Achilles Tendon Thickness as Assessed by Ultrasound and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention.
    Angiology. 2026 Apr 10:33197261441900. doi: 10.1177/00033197261441900.
    PubMed        


    Ann Thorac Surg

  11. BONATTI J
    What if we just leave out stenting in robotically assisted hybrid coronary intervention?
    Ann Thorac Surg. 2026 Apr 8:S0003-4975(26)00313.
    PubMed        


    Arterioscler Thromb Vasc Biol

  12. GALEANO-OTERO I, Dominguez-Liste B, Aspron C, Fernandez-Chacon M, et al
    Orai1 Facilitates Angiogenesis After Myocardial Infarction Through Notch1 Signaling Pathway.
    Arterioscler Thromb Vasc Biol. 2026 Apr 16. doi: 10.1161/ATVBAHA.125.324231.
    PubMed         Abstract available


    Can J Cardiol

  13. WU S, Wang S, Xu F, Pang J, et al
    High Kidney Function in Myocardial Infarction Patients Undergoing Coronary Intervention: Risk of Acute Kidney Injury Risk and Long-term Prognosis.
    Can J Cardiol. 2026 Apr 13:S0828-282X(26)00354.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  14. ZHOU Z, He Y, Pan Y, Duan J, et al
    Successful Percutaneous Revascularization for Acute Myocardial Infarction From Left Main Occlusion and Concomitant Right Coronary Artery Chronic Total Occlusion: A Case Report.
    Catheter Cardiovasc Interv. 2026 Apr 12. doi: 10.1002/ccd.70624.
    PubMed         Abstract available


    Circ J

  15. JEONG JC, Park JI, Choi KU, Nam JH, et al
    Bisoprolol vs. Carvedilol After Percutaneous Coronary Intervention in Acute Myocardial Infarction With Reduced Left Ventricular Ejection Fraction.
    Circ J. 2026 Apr 16. doi: 10.1253/circj.CJ-25-0998.
    PubMed         Abstract available


    Circulation

  16. SHUOLIN L, Chuanyin L, Zhu M, Zhu T, et al
    Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity.
    Circulation. 2026 Apr 17. doi: 10.1161/CIRCULATIONAHA.125.074399.
    PubMed         Abstract available

  17. MURCHLAND AR, Koenen KC, Lawn RB
    Response by Murchland et al to Letter Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
    Circulation. 2026;153:e1119-e1120.
    PubMed        

  18. ZHUANG Z, Huang J, Chi H
    Letter by Zhuang et al Regarding Article, "Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II".
    Circulation. 2026;153:e1117-e1118.
    PubMed        


    Clin Cardiol

  19. OU CZ, Liu ZQ, Xiong YJ, Chen S, et al
    Remnant Cholesterol Inflammatory Index and Its Association With All-Cause Mortality Among General Population and Individuals With Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: Evidence From Two Nationwide Studies.
    Clin Cardiol. 2026;49:e70297.
    PubMed         Abstract available

  20. HAO QY, Li ZH, Weng J, Zhan ZB, et al
    C-Reactive Protein-Triglyceride-Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis.
    Clin Cardiol. 2026;49:e70304.
    PubMed         Abstract available


    Eur Heart J

  21. ROSSELLO X
    Age, frailty, and outcomes in myocardial infarction: a new paradigm for an old concept.
    Eur Heart J. 2026 Apr 9:ehag213. doi: 10.1093.
    PubMed        

  22. GUIDA G, Disabato G, Piepoli M
    A natural experiment in the air: particulate matter and acute myocardial infarction subtypes during the COVID-19 pandemic.
    Eur Heart J. 2026 Apr 9:ehag218. doi: 10.1093.
    PubMed        

  23. OTERO S, Radike M, Ben-Aicha S, Mendieta G, et al
    Cardioprotection with intravenous statin administration during myocardial infarction vs. oral preloading: a preclinical study.
    Eur Heart J. 2026 Apr 15:ehag269. doi: 10.1093.
    PubMed        

  24. ALCOVER S, Ramos-Regalado L, Munoz-Garcia N, Giron GO, et al
    Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction.
    Eur Heart J. 2026 Apr 17:ehag187. doi: 10.1093.
    PubMed         Abstract available


    Int J Cardiol

  25. LIU J, Lyu Q, Li J, He X, et al
    Low-dose telmisartan protects against myocardial ischemia/reperfusion injury via dual mechanisms: AMPK activation and AMPK-independent calcium homeostasis.
    Int J Cardiol. 2026;454:134450.
    PubMed         Abstract available

  26. JIANG T, Chen C, Shao M, Ma J, et al
    The inflammation-microvascular axis in prognosis: Integrated FAI and AMR assessment for risk stratification after PCI in NSTEMI patients.
    Int J Cardiol. 2026;454:134455.
    PubMed         Abstract available

  27. NGUYEN KD, Vu VH, Duong BT, Tran H, et al
    Percutaneous coronary intervention registries in the Asia-Pacific region: A systematic review of methodology and patient characteristics and meta-analysis of in-hospital mortality rate.
    Int J Cardiol. 2026;454:134453.
    PubMed         Abstract available

  28. ABUMAYYALEH M, Behnes M, Akin I, Schupp T, et al
    Is the obesity paradox overstated? The underrecognized role of inflammation in myocardial infarction.
    Int J Cardiol. 2026 Apr 10:134479. doi: 10.1016/j.ijcard.2026.134479.
    PubMed        


    J Am Coll Cardiol

  29. CUTLIP DE, Mehran R, Sharma S, Doros G, et al
    Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis.
    J Am Coll Cardiol. 2026 Apr 2:S0735-1097(26)05722.
    PubMed         Abstract available

  30. BU F, Wu R, Ostropolets A, Aminorroaya A, et al
    Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus.
    J Am Coll Cardiol. 2026 Apr 3:S0735-1097(26)05724.
    PubMed         Abstract available

  31. LI Y, Yan F, Yu L, Xu J, et al
    Visual Acuity and Cardiovascular Mortality in 2.52 Million Older Adults in China.
    J Am Coll Cardiol. 2026 Apr 2:S0735-1097(26)05645.
    PubMed         Abstract available


    Lancet

  32. ZHENG H
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed        

  33. HUNYOR I, Wilcox I, O'Sullivan J
    Contemporary non-invasive imaging for coronary artery disease.
    Lancet. 2026;407:1424.
    PubMed        

  34. VAN DER BIJL P, Bax JJ
    Contemporary non-invasive imaging for coronary artery disease - Authors' reply.
    Lancet. 2026;407:1425.
    PubMed        


    Mol Cell Biochem

  35. BANKELL E, Gidlof O, Nilsson BO
    Pro-inflammatory LPS drives production and release of the chemokine MCP-1 in human coronary artery smooth muscle cells.
    Mol Cell Biochem. 2026 Apr 11. doi: 10.1007/s11010-026-05532.
    PubMed        


    N Engl J Med

  36. CHUAN F, Gao Y, Zhou B
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1550.
    PubMed        

  37. SKEITH L, Bates SM
    Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk.
    N Engl J Med. 2026;394:1514-1528.
    PubMed         Abstract available

  38. BECATTINI C, Agnelli G, Paciaroni M
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1550-1551.
    PubMed        

  39. VAN BRUGGEN F
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551.
    PubMed        

  40. XU H, Cong X, Lin L
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551.
    PubMed        

  41. ANKER MS, Butler J, Anker SD
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.
    N Engl J Med. 2026;394:1551-1553.
    PubMed        

  42. NICHOLLS SJ, Pavo I, D'Alessio D
    Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. Reply.
    N Engl J Med. 2026;394:10.
    PubMed        

  43. SHARMA M, Dong Q, Hirano T, Kasner SE, et al
    Asundexian for Secondary Stroke Prevention.
    N Engl J Med. 2026;394:1467-1479.
    PubMed         Abstract available

  44. LIN S, He Y, He L, Liu Y, et al
    Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease.
    N Engl J Med. 2026;394:1480-1490.
    PubMed         Abstract available


    PLoS Med

  45. SUN Z, Shi M, Zheng Y
    Interpreting circulating microbiome-related metabolites in coronary heart disease.
    PLoS Med. 2026;23:e1005056.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum